Fink Jeffrey Arvin 4
4 · Lipocine Inc. · Filed Jun 10, 2021
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Fink Jeffrey Arvin
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-09$1.26/sh+22,000$27,720→ 22,000 totalExercise: $1.26From: 2022-06-09Exp: 2031-06-09→ Common Stock (22,000 underlying)
Footnotes (1)
- [F1]100% vesting one year from date of grant